A team of researchers, using a yeast model of Alzheimer's disease, have identified a drug that could reduce the level of toxic proteins that prevents cellular damage in the brains of AD patients. "We can use this yeast model to find small molecules that will address the underlying cellular pathologies of Alzheimer's, an age-related disease whose burden will become even more significant as our population grows older," says Kent Matlack, a former staff scientist ...
Read MoreYou have just read an article categorized health
titled Alzheimer's Drug Candidate and Its Mechanism of Action Revealed by New Yeast Model.
Written by:
editor - Thursday, March 6, 2014
There are currently no comments for "Alzheimer's Drug Candidate and Its Mechanism of Action Revealed by New Yeast Model"
Post a Comment